An active metabolite of losartan inhibits arachidonic acid-induced platelet aggregation in isolated human platelet-rich plasma at 10 pM a PPARY agonist (EC50 17 1 UM in COS-7 cells expressing human PPARY using a reporter assay) increases lipid accumulation in 3T3-L1 adipocytes at 10 UM decreases superoxide production by NOX in isolated human PBMCs in a concentration-dependent manner inhibits LPS-induced increases in COX2 mRNA expression and LPS- or angiotensin II-induced increases in supernatant PGF2a levels in HUVECs at 10 UM